Freelancer profile translated to English.
Back to original languageAbout Manuelle
Fractional COO | Opérations Scientifiques Biotech | Oncologie Préclinique | Due Diligence | Levée de fonds
Vous dirigez une biotech oncologie en phase préclinique ou série A?
Vous avez un programme à structurer, un actif à valoriser ou une levée à préparer, mais pas encore la masse critique pour un COO à temps plein?
J'interviens sur des mandats à périmètre défini, avec des livrables précis et une durée déterminée.
Pas de retainer ouvert. Pas de conseil abstrait.
Ce que je livre concrètement :
- Due diligence d'actif oncologie: analyse du package de données, paysage concurrentiel, recommandation go/no-go
- Plan de développement préclinique: séquençage des études, sélection et supervision de CROs, budget et timeline vers le point d'inflexion de valeur
- Préparation à la levée de fonds: deck investisseur, business plan scientifique, différenciation concurrentielle
- Opérations scientifiques: Board materials, gouvernance de programme, reporting investisseurs
Pourquoi moi et pas un cabinet?
Docteure en pharmacologie. 10 ans d'opérations réelles en biotech oncologie au Royaume-Uni. £4,2M levés chez Nodus Oncology. Deux spin-outs créés et structurés (Nodus Oncology, Nuan Bioscience). Plus de 10 due diligences d'actifs réalisées chez Cumulus Oncology.
Je ne sous-traite pas, vous travaillez directement avec moi.
Bilingue français/anglais. Disponible en France, au Royaume-Uni et en Europe.
English
Native or bilingual
French
Native or bilingual
Can work on-site
Montpellier (up to 50km)
Experience
- Nodus Oncology Ltd,Operation's directorBIOTECHSeptember 2022 - February 2025 (2 years and 5 months)Édimbourg, United Kingdom• - Operational and Scientific Leadership Management of the company's day to days operations including strategy execution, scientific pipeline management, Board of director preparations, stakeholder relationship supervision, and fundraising support• - Fundraising and competitive intelligence Distillation of scientific rationale and data, in accessible format, for the production of exciting fundraising deck and business plan to raise investor's interests. £4,2 millions raised in 2 tranches to bring our molecule to clinical candidate. Horizon scanning of the competitive landscape to identify main competitor and create a differentiation for our compound.• - Stakeholder management Working close to the CEO and the CFO to be agile with scientific planning and monitor delivery and timelines against the company's strategy, while ensuring financial health and anticipate the company's runway Working close to the scientific team and CROs to build-up and supervise the development plan's execution and successfully forecast the next phase of developmentAltogether maintaining open communication stream across the company, encouraging outside of the box thinking to successfully tackle difficult situations, human, scientific or financial.
- Cumulus Oncology Ltd,Director of Scientific AffairsBIOTECHJanuary 2019 - February 2025 (6 years and 1 month)Édimbourg, United Kingdom• - Conducting due diligence for innovative asset opportunity to licenseReviewing data package and analysing market opportunity for asset available to license, with thepotential for further development in the oncology field. Coordination of the due diligence process within the team, gathering individual's recommendation and reporting of the conclusion on eachopportunity.• - Company creationBusiness case development for the creation of new companies around pipeline of asset focused on the same theme, including scientific development plan, competitive landscape and market positioning. Spin-out of Nodus Oncology is the first company from Cumulus Oncology, based on DDR assets and development of Nuan Bioscience (still in incubation – soon to be the third spin out), based mAbs and ADCs. Creation of fundraising deck and opportunity deck for each opportunity• - Scientific operations leadership Create preclinical development plan based on due diligence findings on innovative assets. Management external communication with CROs to plan activities and resources needed to reach value inflection point
- The University of Oxford BrookesEntrepreneurial Lead - iCURE ProgrammeCHEMICALJune 2019 - September 2019 (3 months)Oxford, United Kingdom• - Business development and investor engagement Conducting strategic analysis, market opportunity assessments and due diligence, for a technology enabling oral bioavailability rising from Oxford Brookes University. Business development andrelationship management internally with leading academics, and externally with investors, Pharma & biotech companies in the field to determine how to position the technology and source financialsupport. Preparing compelling communication materials including presentation for investors to find matchfunding to complement regional funding opportunity.
Recommendations
Be the first to recommend Manuelle
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- Executive EducationBabson College2014Executive Education
- PRINCE2 Practitioner - Project Management qualificationAPMG-International2013PRINCE2 Practitioner - Project Management qualification